Table 1 FAST vaccines peptides selected and positive rates per cancer-type studied in mice model
From: Comparison of personal and shared frameshift neoantigen vaccines in a mouse mammary cancer model
Vaccine | Peptides | Positive rates (%) | |
|---|---|---|---|
Cancer Samples | |||
Breast | Pancreatic | ||
BC-FAST | CIMpep404 | 83.3 | 0 |
CIMpep368 | 54.2 | 6 | |
CIMpep131 | 37.5 | 0 | |
CIMpep187 | 33.3 | 28 | |
CIMpep1 | 33.3 | 100 | |
CIMpep332 | 29.2 | 0 | |
CIMpep450 | 29.2 | 0 | |
CIMpep491 | 29.2 | 11 | |
CIMpep64 | 29.2 | 44 | |
CIMpep14 | 29.2 | 89 | |
PC-FAST | CIMpep145 | 0 | 78 |
MS-75 | 0 | 100 | |
CIMpep105 | 4.2 | 33 | |
CIMpep3 | 4.2 | 28 | |
MS-76 | 4.2 | 94 | |
CIMpep479 | 12.5 | 50 | |
CIMpep282 | 16.7 | 44 | |
CIMpep493 | 16.7 | 33 | |
CIMpep7 | 25 | 28 | |
CIMpep362 | 29.2 | 89 | |